A Single-Center Experience With Isolated Limb Infusion: An Interventional Oncology Opportunity.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 27897028.
- Also identified by DOI 10.2214/AJR.16.16344.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This retrospective review details our experience with isolated limb infusion for the treatment of melanoma, squamous cell carcinoma, and sarcoma in-transit metastases performed entirely in the interventional radiology suite. Eleven patients were treated over a 3-year period. Treatment response was assessed clinically and with PET/CT. Eight patients had either complete or partial response, giving an overall response rate of 72%. Isolated limb infusion can efficiently be performed entirely in the interventional radiology suite.
Medical subject headings
- Antineoplastic Agents
- Chemotherapy, Cancer, Regional Perfusion
- Melanoma
- Radiography, Interventional
- Sarcoma